分子檢測法市場：按技術、按產品分類 - 2025-2030 年全球預測

2023年分子檢測法市場價值為22.9億美元，預計到2024年將達到24.2億美元，複合年成長率為6.83%，到2030年將達到36.4億美元。

分子檢測法市場包括分子生物學中使用的各種技術，主要集中於核酸和蛋白質的分析，以促進生物標記的檢測、表徵和定量。這些技術包括聚合酵素鏈鎖反應(PCR)、定序技術、微陣列以及醫療保健、農業、環境研究和製藥等各個領域所必需的其他先進生化技術。對個人化醫療、標靶治療和旨在提高治療效果和患者預後的先進診斷工具的需求不斷成長，推動了對分子檢測法的需求。其用途範圍從研究和基因組研究到臨床診斷和藥物開發。最終用戶包括醫院、研究機構、生技公司、農業等。影響市場的關鍵成長要素包括定序和生物資訊學的技術進步、精準醫學的興起以及基因研究資金的增加。此外，COVID-19 大流行凸顯了分子診斷和加速市場採用的重要性。 CRISPR 技術的擴展、次世代定序儀(NGS) 應用的開發以及生物標記的發現存在潛在的商機。然而，高成本、監管障礙和對熟練人員的需求等挑戰阻礙了市場的加速成長。創新和研究最好針對自動化，以降低成本並提高可訪問性，利用人工智慧增強資料分析能力，並探索合成生物學和基因編輯的新穎應用。市場格局是動態的，對於能夠應對技術複雜性和監管環境的公司來說，存在著巨大的機會。鼓勵公司透過投資夥伴關係和研究合作、利用新興技術以及為利基和更廣泛的應用開發全面的解決方案來滿足未來的市場需求。

市場動態：揭示快速發展的分子檢測法市場的關鍵市場洞察

供需的動態交互作用正在改變分子檢測法市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

• 市場促進因素
  • 食品安全需求不斷成長
  • 感染疾病流行率不斷上升
  • 環境工程的應用不斷增加
• 市場限制因素
  • 嚴格的核准監管標準
• 市場機會
  • 分子技術的持續研發與進步
  • 基因組研究進展
• 市場挑戰
  • 分子檢測法的本質局限性

波特五力：駕馭分子檢測法市場的策略工具

波特的五力架構是了解分子檢測法市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解分子檢測法市場的外部影響

外部宏觀環境因素在塑造分子檢測法市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解分子檢測法市場的競爭狀況

分子檢測法市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣分子檢測法市場供應商的績效評估

FPNV定位矩陣是評估分子檢測法市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了檢測法市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，分子檢測法市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 食品安全需求不斷成長
    • 感染疾病傳播加劇
    • 環境工程的應用不斷增加
  • 抑制因素
    • 嚴格的核准監管標準
  • 機會
    • 分子技術的持續研究、開發與進步
    • 基因組學領域發展加速
  • 任務
    • 分子檢測法的固有局限性
• 市場區隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 經濟
  • 社群
  • 技術的
  • 合法地
  • 環境

第6章分子檢測法市場：依技術分類

• 生物感測器
• 免疫檢測
• 微陣列
• 聚合酵素鏈鎖反應

第7章分子檢測法市場：依產品

• 裝置
• 試劑/耗材
• 服務

第8章美洲分子檢測法市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章亞太地區分子檢測法市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章歐洲、中東和非洲的分子檢測法市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭格局

• 2023 年市場佔有率分析
• FPNV 定位矩陣，2023
• 競爭情境分析
• 戰略分析和建議

公司名單

• 3m Company
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Danaher Corporation
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd
• HiMedia Laboratories LLC
• Invitae Corporation
• Neogen Corporation
• QIAGEN GmbH
• Sekisui Chemical Co., Ltd.
• SGS SA
• Siemens AG
• Thermo Fisher Scientific Inc.

The Molecular Methods Market was valued at USD 2.29 billion in 2023, expected to reach USD 2.42 billion in 2024, and is projected to grow at a CAGR of 6.83%, to USD 3.64 billion by 2030.

The molecular methods market encompasses various techniques used in molecular biology, primarily focusing on the analysis of nucleic acids and proteins, to facilitate the detection, characterization, or quantification of biomarkers. These methods include polymerase chain reaction (PCR), sequencing technologies, microarrays, and other sophisticated biochemical methods that are essential across various sectors such as healthcare, agriculture, environmental studies, and pharmaceuticals. The necessity of molecular methods is driven by the growing demand for personalized medicine, targeted therapies, and advanced diagnostic tools aiming to enhance treatment efficacy and patient outcomes. Applications range from research and genomic studies to clinical diagnostics and pharmaceutical development. End-users include hospitals, research institutions, biotechnology firms, and agricultural industries, among others. Key growth factors influencing the market include technological advancements in sequencing and bioinformatics, the rise of precision medicine, and increased funding for genetic research. Additionally, the COVID-19 pandemic has underscored the importance of molecular diagnostics, accelerating market adoption. Potential opportunities lie in the expansion of CRISPR technology, development of next-generation sequencing (NGS) applications, and biomarker discovery. However, challenges such as high costs, regulatory hurdles, and the need for skilled personnel impede faster market growth. Innovation and research are best directed at automating molecular methods to reduce costs and improve accessibility, enhancing data analysis capabilities through AI, and exploring novel applications in synthetic biology and gene editing. The market's nature is dynamic, with significant opportunities for those who can navigate technological complexities and regulatory landscapes. Companies are advised to invest in partnerships and research collaborations to capitalize on emerging technologies and develop comprehensive solutions that serve both niche and broad applications, thereby aligning with future market demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Molecular Methods Market

The Molecular Methods Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing demand for food safety
  • Rising prevalence of infectious diseases
  • Increasing applications in environmental engineering
• Market Restraints
  • Stringent regulatory norms for approval
• Market Opportunities
  • Ongoing R&D and advancements in molecular techniques
  • Rising developments in genomics filed
• Market Challenges
  • Intrinsic limitations of molecular methods

Porter's Five Forces: A Strategic Tool for Navigating the Molecular Methods Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Molecular Methods Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Molecular Methods Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Molecular Methods Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Molecular Methods Market

A detailed market share analysis in the Molecular Methods Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Molecular Methods Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Molecular Methods Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Molecular Methods Market

A strategic analysis of the Molecular Methods Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Molecular Methods Market, highlighting leading vendors and their innovative profiles. These include 3m Company, Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd, HiMedia Laboratories LLC, Invitae Corporation, Neogen Corporation, QIAGEN GmbH, Sekisui Chemical Co., Ltd., SGS SA, Siemens AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Molecular Methods Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Biosensors, Immunoassay, Microarray, and Polymerase Chain Reaction.
• Based on Product, market is studied across Instrument, Reagents & Consumables, and Services.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for food safety
    • 5.1.1.2. Rising prevalence of infectious diseases
    • 5.1.1.3. Increasing applications in environmental engineering
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory norms for approval
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing R&D and advancements in molecular techniques
    • 5.1.3.2. Rising developments in genomics filed
  • 5.1.4. Challenges
    • 5.1.4.1. Intrinsic limitations of molecular methods
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Molecular Methods Market, by Technology

• 6.1. Introduction
• 6.2. Biosensors
• 6.3. Immunoassay
• 6.4. Microarray
• 6.5. Polymerase Chain Reaction

7. Molecular Methods Market, by Product

• 7.1. Introduction
• 7.2. Instrument
• 7.3. Reagents & Consumables
• 7.4. Services

8. Americas Molecular Methods Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Molecular Methods Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Molecular Methods Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3m Company
• 2. Abbott Laboratories
• 3. Bio-Rad Laboratories, Inc.
• 4. bioMerieux SA
• 5. Danaher Corporation
• 6. Eurofins Scientific
• 7. F. Hoffmann-La Roche Ltd
• 8. HiMedia Laboratories LLC
• 9. Invitae Corporation
• 10. Neogen Corporation
• 11. QIAGEN GmbH
• 12. Sekisui Chemical Co., Ltd.
• 13. SGS SA
• 14. Siemens AG
• 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. MOLECULAR METHODS MARKET RESEARCH PROCESS
• FIGURE 2. MOLECULAR METHODS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MOLECULAR METHODS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. MOLECULAR METHODS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. MOLECULAR METHODS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MOLECULAR METHODS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MOLECULAR METHODS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MOLECULAR METHODS MARKET DYNAMICS
• TABLE 7. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MOLECULAR METHODS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MOLECULAR METHODS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MOLECULAR METHODS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MOLECULAR METHODS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MOLECULAR METHODS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MOLECULAR METHODS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. CANADA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. CANADA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CHINA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. CHINA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. INDIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. INDIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ITALY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. ITALY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. POLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. POLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. QATAR MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. QATAR MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. MOLECULAR METHODS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. MOLECULAR METHODS MARKET, FPNV POSITIONING MATRIX, 2023